All lobbying filings

KELLEY DRYE & WARREN LLP

Lobbying for TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Development of federal public policy and advocacy strategy and lobbying federal government

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 7

HR 2586
Reentry Act of 2025
HR 1510
Due Process Continuity of Care Act
S 1720
Due Process Continuity of Care Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 2741
PEER Support Act
S 1329
PEER Support Act
S 3522
No Red Tape For Addiction Treatment Act

Lobbying activity 1

Health Issues

Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); PEER Support Act (H.R. 2741 / S. 1329); No Red Tape For Addiction Treatment Act (S. 3522); and WORK To Save Lives Act (draft legislation in House and Senate); FY2026 appropriations language related to substance use prevention and treatment

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.